Nab-paclitaxel + Gemcitabine + VCN-01 oncolytic adenovirus (zabilugene almadenorepvec)

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Nab-paclitaxel + Gemcitabine + VCN-01 oncolytic adenovirus (zabilugene almadenorepvec)
Treatment and conditionWhere it standsTrials
Nab-paclitaxel + Gemcitabine + VCN-01 oncolytic adenovirus (zabilugene almadenorepvec) for neoplasm metastasisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1